Copyright
©The Author(s) 2019.
World J Gastroenterol. Apr 14, 2019; 25(14): 1764-1774
Published online Apr 14, 2019. doi: 10.3748/wjg.v25.i14.1764
Published online Apr 14, 2019. doi: 10.3748/wjg.v25.i14.1764
Table 4 Diagnostic accuracy of 80% Crohn’s Disease Endoscopic Index of Severity reduction at week 14 for the diagnosis of long-term mucosal healing
| Mucosal healing at week 46 | ||||
| No | Yes | |||
| ≥ 80% reduction in CDEIS at week 14 from baseline | No | n (%) | 32 (74.4) | 11(25.6) |
| Yes | n (%) | 3 (15.8) | 16 (84.2) | |
- Citation: Alfaro I, Masamunt MC, Planell N, López-García A, Castro J, Gallego M, Barastegui R, Giner A, Vara A, Salas A, Ricart E, Panés J, Ordás I. Endoscopic response to tumor necrosis factor inhibitors predicts long term benefits in Crohn’s disease. World J Gastroenterol 2019; 25(14): 1764-1774
- URL: https://www.wjgnet.com/1007-9327/full/v25/i14/1764.htm
- DOI: https://dx.doi.org/10.3748/wjg.v25.i14.1764